In addition to EGFR, c-Met and Akt reduction, this study also found that combination treatment significantly lowered tumour growth on xenograft mice models and more importantly, 60 mg/kg of gefitinib combined with 1 g/kg of curcumin showed comparable results to 120 mg/kg of gefitinib. The gene discussed is MET; the disease is neoplasm.